Match Document Document Title
9107441 Composition for reducing absorption of dietary fat  
This invention relates to compositions for reducing the absorption or bioavailability of lipids in the gastrointestinal tract, and to methods for the preparation and use of these compositions. The...
9040078 Use of lipid conjugates in the treatment of diseases of the nervous system  
The invention provides a method for treating a subject suffering from a disease of the central nervous system which is associated with an inflammatory response, including, inter alia, multiple...
9034844 6′-sialyllactose salts and process for their synthesis and for the synthesis of other alpha-sialyloligosaccharides  
The present invention relates to a process of synthesis of α-sialyl oligosaccharides and in particular of 6′-sialyllactose and its salts comprising a step of coupling by Koenigs-Knorr reaction...
9034843 Ophthalmic composition  
The present invention provides an ophthalmic composition which stabilizes the tear film during wearing contact lens, prevents eye dryness, imparts a favorable sensation in using, is highly...
9029347 Method and mixture for treating and preventing inflammatory bowel disease  
A method and a mixture for treating and preventing the inflammatory bowel disease (IBD) by applying a predetermined therapeutically effective amount of a mixture of hyaluronic acid to individuals...
9028883 Compositions for the treatment of hemorrhoids and related diseases  
The present invention relates to pharmaceutical, nutraceutical, health foods and medical device compositions comprising polysaccharides from Opuntia Ficus Indica cladodes in combination with...
9029349 Bioadhesive for tissue repair  
The invention provides a bioadhesive composition comprising a polysaccharide and an energy converter, wherein the energy converter is activated by non-UV light. The composition may be prepared by...
9023830 Cosmetic  
There is disclosed a cosmetic comprises a sugar compound obtained by reacting a hydroxyl group of a saccharide, an isocyanate group-containing organopolysiloxane represented by the following...
9023827 Active ingredient with cutaneous application obtained from metschnikowia agaves and uses for improving the state of the skin  
An active ingredient with cutaneous application obtained from Metschnikowia agaves, as well as its use for preventing and/or combating ageing of the skin and its visible manifestations, and...
9023828 Composition comprising at least one alginate for use in treatment and/or prevention of overweight  
The present invention relates to a composition in the form of a powder or a viscous paste, and which includes at least one low viscosity alginate having a viscosity of less than about 100 mPaS in...
9023333 Method of using shaped articles to apply a scaffold-forming agent to an external skin and/or hair surface of a human or an animal  
The invention relates to the use of a shaped article containing at least one skeleton-forming agent, proteins being excepted, optionally one or more active substances and also optionally one or...
9023831 Methods and compositions of inhibiting complement and cellular activation with Dextran Sulfate  
A method of inhibiting the adverse effects of complement pathway, activation products in a subject comprising administering to the subject an amount of Dextran Sulfate effective to inhibit...
9018158 Alginate oligomers for use in overcoming multidrug resistance in bacteria  
The invention provides a method of overcoming resistance to at least one antibiotic in a multidrug resistant bacterium, said method comprising contacting said bacterium with an alginate oligomer...
9012396 Use of lipid conjugates in the treatment of conjunctivitis  
In one embodiment, the invention provides a method of suppressing, inhibiting, preventing, or treating conjunctivitis in a subject, comprising the step of administering an effective amount of a...
9011894 Sterile hyaluronic acid polymer compositions and related methods  
The present application provides sterile hyaluronic polymer compositions than are useful, e.g., as medical devices, biomedical adhesives, and sealants. Generally, provided are sterile dry...
9012415 Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof  
This invention refers to photo-crosslinked hydrogel materials based in gellan gum suitable for tissue engineering and regenerative medicine applications or as drug delivery systems. Formulations...
9012413 FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof  
The invention relates to FGF receptor-activating N-acyl octasaccharides having Formula (I), wherein: R1 is an O-alkyl group optionally replaced by one or more aryl or cycloalkyl groups, R2 is an...
9006213 Injectable cross-linked polymeric preparations and uses thereof  
A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room...
9006212 Compositions and methods for pest control  
Provided herein are compositions and kits comprising carbohydrate-based inhibitors that bind GNBP and/or inhibit β(1,3)-glucanase activity. Also provided are methods of using such inhibitors to...
9006214 Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye  
The present invention is directed to a topical ophthalmic composition for a liquid comprised of clear colloidal polar nanolipids delivered in submicron sized particles, aqueous colloidal...
9006208 Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y2 receptor agonist and hyaluronic acid or salt thereof  
An agent for treatment of dry eye comprising a combination of a P2Y2 receptor agonist at a therapeutically effective concentration and hyaluronic acid or a salt thereof at a therapeutically...
8999942 Polyol modified aminoglycoside-lipid conjugates  
In some aspects, the present invention provides aminoglycoside derivatives thereof that exhibit antibacterial activity. In some aspects, the aminoglycoside derivatives comprise compounds...
8999953 Cyclodextrin nanotechnology for ophthalmic drug delivery  
The invention provides an ophthalmic composition which is an aqueous suspension comprising drug, cyclodextrin and water, the composition having an aqueous phase of from about 0.1% (w/v) to about...
8999066 Bleached dextrin and methods of forming same  
A method of forming a bleached dextrin, comprising combining a dextrin-based composition selected from the group consisting of starch dextrin, cyclodextrins, inulin, hydrogenated indigestible...
8993539 Dietary fiber supplements for appetite suppression  
The present invention provides a composition of dietary fiber supplements for satiety enhancement and appetite suppression in treatment of overweight, obesity, or eating disorders. The composition...
8992999 Methods and compositions for controlling parasitic infections of animals  
A composition for preventing or reducing harmful effects of protozoal infection is provided, comprising in one embodiment a yeast cell wall and a preparation derived from oregano. The composition...
8993538 Injectable cross-linked polymeric preparations and uses thereof  
A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room...
8993299 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same  
The present invention relates to polypeptides having cellobiohydrolase I activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to...
8993537 Forming porous scaffold from cellulose derivatives  
Scaffold comprises a polymer defining macropores and comprising hydroxypropylcellulose partially substituted by a substituent comprising a self-crosslinkable group, which is crosslinked through...
8993536 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same  
A low-molecular-weight polysulfated hyaluronic acid derivative useful for treatment of an allergic disease. An agent for treatment of an allergic disease selected from pollinosis, allergic...
8986746 Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease  
The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of...
8987231 Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved  
The present invention describes sulodexide or at least one of its components for use in the reduction of circulating matrix metalloproteinase (MMPs), in particular MMP-9. Sulodexide and its...
8987229 Semi-fluid food product comprising beta-glucan fibres  
The present invention relates to a semi-fluid thermized aqueous solution comprising β-glucan fibers and a sufficient amount of at least one viscosity depressant chosen from the group composed of...
8986716 Fructan-based epilatory compositions  
The invention relates to an epilatory mixture comprising a fructan, preferably inulin. Furthermore, an epilatory composition is disclosed comprising said epilatory effective mixture. Also a method...
8986969 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same  
The present invention relates to polypeptides having cellobiohydrolase I activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to...
8987215 Composition for use in gene therapy  
A composition useful in gene therapy and a method of treatment to effect gene therapy is provided. In particular, a pharmaceutical composition comprising a nonimmunogenic net polyanionic...
8986667 Cosmetic composition with skin tightening effect  
The present invention relates to a mixture, having a skin-tightening effect, which is made up of: 10 to 80% by weight of a polysaccharide, preferably of an alginate, having a molecular weight of...
8986745 Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin  
There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from...
8987230 Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same  
The present invention provides a composition comprising a hyaluronic acid derivative having a crosslinking group(s) and a hydrophilic polysaccharide derivative having a hydrophobic group(s),...
8980866 Complex obtained from hyaluronic acid or a salt thereof and chondroitin sulphate mixtures  
The present invention relates to a novel complex, obtainable by mixing hyaluronic acid or a salt thereof and chondroitin sulphate or a salt thereof, and forming an aqueous solution of said...
8979821 Lacrimal filler  
A biomaterial mass is inserted through a punctum into a canaliculus in the lacrimal outflow system with a syringe. The mass has an outer cross section that is less than the inner cross section of...
8974796 Agent for preventing adverse side effects of carcinostatic agent  
The present invention provides a side effect inhibitor of drug therapy for colorectal cancer using 5-fluorouracil, comprising fucoidan or a fucoidan-containing material; a method for inhibiting...
8975240 Peritoneal dialysis solutions comprising glucose polymers  
Peritoneal dialysis solutions including a glucose polymer and methods of using the dialysis solutions are disclosed herein. In a general embodiment, the peritoneal dialysis solution includes a...
8974833 Combination of an oxidant and a photoactivator for the healing of wounds  
There is provided a wound healing composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant and at least one healing factor chosen from...
8969320 Hyaluronic acid derivatives containing groups able to release NO  
Disclosed are hyaluronic acid derivatives functionalized with S-nitrosothiol groups of the general formula: wherein HA indicates hyaluronic acid and G indicates a suitable spacer.
8969319 Agent for applying to mucosa and method for the production thereof  
An agent for applying to mucosa capable of persistently exerting a therapeutic effect on disorders such as inflammation and lesions in the mucosa even by a lower frequency of administration...
8968751 Topical compositions associating sodium hyaluronate fragments and retinoid useful for cosmetic and medical dermatology  
The inventive compositions for topical application are characterized in that they comprises one or several hyaluronate fragments in the form of a main principle whose molecular weight ranges from...
8968792 Pharmaceutical combination for the treatment of renal failure in pets  
The present invention relates to a pharmaceutical combination for the treatment of renal failure in pets, caused by various diseases or ineffective to traditional renal therapy or renal...
8968722 Milk-based nutritional compositions containing lactoferrin and uses thereof  
The present disclosure relates to milk-based nutritional compositions comprising lactoferrin and/or a prebiotic component, wherein, when combined, the lactoferrin and prebiotic component may...
8956638 Biocompatible poly (amic acid) and method of preparation thereof  
A method is provided for the preparation of a poly(amic acid) in which ring opening polymerization is employed to react the monomers ethylenediaminetetraacetic dianhydride and paraphenylenediamine...